Cargando…
Editorial: Immunogenicity of Proteins Used as Therapeutics
Autores principales: | Sauna, Zuben E., Richards, Susan M., Maillere, Bernard, Jury, Elizabeth C., Rosenberg, Amy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658604/ https://www.ncbi.nlm.nih.gov/pubmed/33193460 http://dx.doi.org/10.3389/fimmu.2020.614856 |
Ejemplares similares
-
Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
por: Sauna, Zuben E., et al.
Publicado: (2023) -
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
por: Jankowski, Wojciech, et al.
Publicado: (2023) -
Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023) -
SampPick: Selection of a Cohort of Subjects Matching a Population HLA Distribution
por: McGill, Joseph R., et al.
Publicado: (2019) -
Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins
por: Zichel, Ran, et al.
Publicado: (2012)